In this study, we compared the levels of neutralizing antibodies induced by inactivated rabies vaccine in cattle by using three alternative immunization procedures. Forty-five bovines (breed nelore) were then organized in three groups (A, B and C, with 15 animals/group). Group A received only one vaccine dose at day zero and Group B received the first dose at day zero and then another dose at day 30 (early booster). Group C was also immunized with two doses; however, the booster was postponed until day 180 after the first dose (delayed booster). Blood samples were withdrawn at days zero (before the first dose) and 30, 210, 390, and 540 after the beginning of immunization and the antibody titers were evaluated by mouse neutralization test. The protocol used to immunize Group C (booster at day 180) was clearly more efficient. In this group, antibody levels were higher and also remained higher for longer periods in comparison with the other two groups. These results show that booster timing significantly affected antibody levels. Therefore, programs addressed to control this disease in cattle should consider not only the use of a booster but also its administration time.
INTRODUCTION
Rabies is transmitted to cattle by different animals in different regions of the world. In Latin America, the vampire bat (Desmodus rotundus) is the main transmitter of this disease to livestock (7) . According to information from the Brazilian Ministry of Agriculture, it is estimated that nearly 30,000 bovines are lost every year in Brazil due to this infection. Besides obvious economical costs, this high rabies incidence also increases the risk of rabies transmission to other animals (1) . Extermination of vampire bat colonies with anticoagulants has been used to control rabies dissemination to cattle (8, 16) . However, vaccination of bovine herds has been the most effective strategy to control the disease in bovines.
Studies have demonstrated that Brazilian inactivated vaccines are safer and are, at least, as efficient as attenuated live virus vaccines (5, 13) . However, single doses of rabies vaccines have been associated with low levels of neutralizing antibodies and also with occurrence of disease in vaccinated animals (9, 15) . On the other hand, the use of a booster has significantly increased antibody specific levels (2, 6, 10, 14, 17) .
Based on these experimental observations, the Brazilian Program for Rabies Control in bovines has suggested the use of a booster to assure the induction of higher and therefore protective antibody levels. The choice of the timing for this booster is not very well established in cattle.
In the present study, we investigated the effect of a booster on the neutralizing antibodies level induced by an inactivated rabies vaccine (BGS-Cell) in bovines.
Three distinct experimental groups were compared: Group A (only one vaccine dose); Group B (one dose plus one booster, 30 days apart); and Group C (one dose plus one booster, 180 days apart).
MATERIALS AND METHODS

Animals
Forty-five bovines (breed nelore) with approximately 1 year old, maintained in Boa Esperança Farm, Presidente Prudente, Brazil, were used. The animals were routinely inspected by a veterinarian and randomly distributed in 3 experimental groups (A, B and C) with 15 animals each and subjected to different immunization procedures.
Swiss outbreed mice were used in neutralization assays to evaluate specific antibody levels induced by vaccination. Bovines allocated in Groups A, B and C were initially immunized with one vaccine dose (2 ml). Animals from Groups B and C received a booster (also 2 ml) after 30
and 180 days, respectively.
Virus and serum samples
The virus suspension to be used in mouse neutralization test (MNT) was prepared from the brain (20% homogenate in phosphate buffered saline) of mice infected with
Challenge Virus Standard kindly donated by Laboratory of Animal Reference (LARA), Campinas, Brazil.
Blood samples from bovines were collected from the jugular vein before vaccination and also at days 30, 210, 390, and 540 after beginning the vaccination schedule.
Mouse neutralization test (MNT)
The MNT was done according to Fitzgerald (4), adopting the 5-fold serial dilution. were subjected to logarithmic transformation, using log 10 (x+1) and then analyzed by ANOVA and unpaired t test, using α=0.05 (12) .
RESULTS
Individual antibody titers observed in animals from Groups A, B and C are shown in Tables 1, 2 and 3, respectively.
Thirty days after administration of the first rabies vaccine dose, all animals, except one (number 44), produced significant amounts of specific antibodies detected by MNT. Antibody levels were similar, as expected, in the three groups and geometric 100% in Groups A, B and C, respectively. At day 390, a significant drop in the geometric mean titers was observed in Group C comparing with day 210. However, this value was still significantly higher than the ones observed in Groups A and B.
The percentage of titers ≥ 0.5 IU/ml was also significantly higher (100%) than the ones detected in Groups A (86.6%) and B (73.3%). At day 540, the geometric mean titers were similar among the three groups: 1.29, 1.48 and 1.64 in Groups A, B and C, respectively. However, in Group C all animals had titers higher than 0.5 IU/ml, comparing with Groups A (46.6%) and B (66.6%). In this context, the efficacy of three alternative vaccination procedures, employing the inactivated BGS-Cell vaccine was compared. Three experimental groups were used:
Group A: only one vaccine dose; Group B: two doses given 30 days apart; and Group C: two doses given 180 days apart. The humoral immune response was evaluated in bovine serum samples by using the mouse neutralization test (MNT).
MNT results were analyzed according to the World Health Organization, which established values ≥ 0.5 IU/ml as indicators of protection, being necessary the administration of a booster if the value is under this limit (18) .
By checking the presence of specific antibodies in samples collected before the immunization procedure, we certified that all animals were free of specific rabies antibodies and could, therefore, be included in the study.
The antibody profile was very similar between Groups A and B during almost all periods of investigation. In addition, a significant drop in antibody titers was detected at days 210, 390 and 540. These results show that a booster given 30 days after the first dose was not improving the humoral response as expected.
Interestingly, the antibody profile observed in Group C was very distinct from that of Groups A and B. As expected, there was a significant increase in antibody titers at day 210 (30 days after the booster). In this case, the percentage of titers ≥ 0.5 IU/ml was 93.3% and therefore much higher than the values detected in the two other groups. This observation is very interesting not only because it is original but also because it has a very important application in the field of animal health. The Brazilian
Program for Rabies Control has suggested the use of a booster in cattle vaccination.
However, the most adequate period for this second dose was not appropriately investigated until now. Our results indicate, therefore, that a latter booster, given for example at 180 days after the first vaccine dose, is more adequate than an earlier booster, because it triggers a higher and long lasting immune response. One aspect that we considered very relevant in this work was the extended period of serum antibody levels evaluation. A few authors have done this prolonged follow up.
Even though we restricted this evaluation to the inactivated vaccine donated by Hertape Laboratory, we believe that other factors can also modify the final result.
Therefore, factors as kind of vaccine (inactivated or attenuated), manufacturer, stock conditions, and mainly the antigenic vaccine value must be checked before the adoption of a certain vaccine schedule.
The molecular and cellular mechanisms that determined a better response in Group C (delayed booster) in comparison with Group B (early booster) were not investigated. One possibility is that at day 30 the amount of antigen from the first dose was still enough for a good immune response. In this case, an extra antigen supply would not induce a better response. Another possibility, that does not exclude the first one, is that memory cells were not fully developed after 30 days from the first vaccine dose. In this case, the antigen would not interact with memory cells and, consequently, would not induce an anamnestic immune response. In addition, we could think that at day 30 the anti-rabies antibody levels were still too high and could neutralize the injected antigen.
These results support the Brazilian Program for Rabies Control that stresses the need of a booster. In addition, these results alert for the necessity to check the best moment to give the booster in rabies prophylaxis.
